Critical Medicines Act (CMA)

This proposal aims to ensure the availability of essential medicines within the EU. It addresses potential shortages and strengthens the supply chain for critical pharmaceutical products.

The Act will affect pharmaceutical companies, healthcare providers, and patients by improving access to vital medicines and enhancing the EU's resilience to health crises.